These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 778765)

  • 21. Alien-driven diversity and alien-selected escape: a rationale for allogeneic cancer immunotherapy.
    Sondel PM; Hank JA
    Transplant Proc; 1981 Dec; 13(4):1915-21. PubMed ID: 7036482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The immunology of cancer.
    Angel Basombrío M
    J Oral Pathol; 1973; 2(5):231-53. PubMed ID: 4207800
    [No Abstract]   [Full Text] [Related]  

  • 23. Mini-review: overcoming tumor-intrinsic resistance to immune effector function.
    Ganss R; Arnold B; Hämmerling GJ
    Eur J Immunol; 2004 Oct; 34(10):2635-41. PubMed ID: 15368278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A guinea pig model for tumor immunology. A summary.
    Rapp HJ
    Isr J Med Sci; 1973 Mar; 9(3):366-74. PubMed ID: 4122812
    [No Abstract]   [Full Text] [Related]  

  • 25. Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance.
    Mapara MY; Sykes M
    J Clin Oncol; 2004 Mar; 22(6):1136-51. PubMed ID: 15020616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New possibilities for cancer therapy with advances in cancer immunology.
    MacLean GD; Longenecker BM
    Can J Oncol; 1994 Apr; 4(2):249-54. PubMed ID: 7516257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B-cell depletion using an anti-CD20 antibody augments antitumor immune responses and immunotherapy in nonhematopoetic murine tumor models.
    Kim S; Fridlender ZG; Dunn R; Kehry MR; Kapoor V; Blouin A; Kaiser LR; Albelda SM
    J Immunother; 2008 Jun; 31(5):446-57. PubMed ID: 18463540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Tumor immunology].
    Bergheden C
    Nord Med; 1966 Oct; 76(41):1173-9. PubMed ID: 5927234
    [No Abstract]   [Full Text] [Related]  

  • 29. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospects for tumor immunotherapy in man, with emphasis on its use as an adjunct to surgery for primary operable cancer.
    Southam CM
    J Med Liban; 1975; 28(1):43-66. PubMed ID: 1107552
    [No Abstract]   [Full Text] [Related]  

  • 31. The significance of embryonic reexpression in cancer.
    Medawar P; Hunt R
    Cancer Res; 1976 Sep; 36(9 PT 2):3453-4. PubMed ID: 975103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor-specific transplantation immunity to intracerebral challenge with cells from a methylnitrosourea- induced brain tumor.
    Denlinger RH; Axler DA; Koestner A; Liss L
    J Med; 1975; 6(3-4):249-59. PubMed ID: 1059719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel antigenic markers of human tumor regression.
    Fareed GC; Mendiaz E; Sen A; Juillard GJ; Weisenburger TH; Totanes T
    J Biol Response Mod; 1988 Feb; 7(1):11-23. PubMed ID: 3373233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The immunology of tumors.
    Burk MW; Mckhann CF
    Surg Annu; 1973; 5():1-29. PubMed ID: 4602210
    [No Abstract]   [Full Text] [Related]  

  • 35. Animal models of cancer immunotherapy: questions of relevance.
    Weiss DW
    Cancer Treat Rep; 1980; 64(2-3):481-5. PubMed ID: 7407787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unique tumor antigens: evidence for immune control of genome integrity and immunogenic targets for T cell-mediated patient-specific immunotherapy.
    Sensi M; Anichini A
    Clin Cancer Res; 2006 Sep; 12(17):5023-32. PubMed ID: 16951217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of a cloned ultraviolet radiation (UV)-induced suppressor T cell line that is capable of inhibiting anti-UV tumor-immune responses.
    Roberts LK
    J Immunol; 1986 Mar; 136(5):1908-16. PubMed ID: 2936813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tum- variants and the detection of tumor-specific transplantation antigens on spontaneous mouse tumors.
    Boon T; van Pel A; Uyttenhove C; Marchand M; Lambotte P
    Behring Inst Mitt; 1984 May; (74):209-13. PubMed ID: 6332616
    [No Abstract]   [Full Text] [Related]  

  • 39. Direct identification of human tumor-associated peptide antigens and a preclinical model to evaluate their use.
    Engelhard VH; Bullock TN; Colella TA; Mullins DW
    Cancer J; 2000 May; 6 Suppl 3():S272-80. PubMed ID: 10874498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Tumor immunology].
    Milas L; Silobrcić V
    Lijec Vjesn; 1970; 92(1):5-33. PubMed ID: 4932237
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.